Researchers have been excited about the medication , a groundbreaking dual agonist showing remarkable data in initial trials for weight loss . It functions by targeting several systems: GLP-1 and GIP, https://monicaeblr692244.blogtov.com/21463964/the-new-prospect-for-body-management